PCS
BSX icon

Personal CFO Solutions’s Boston Scientific BSX Stock Holding History

Personal CFO Solutions’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,939
Closed -$310K – 535
2026
Q1 		$310K Sell
4,939
-4,139
-46% -$331K 0.04% 367
2025
Q4 		$866K Buy
9,078
+403
+5% +$39.5K 0.14% 143
2025
Q3 		$847K Buy
8,675
+5,882
+211% +$609K 0.15% 138
2025
Q2 		$300K Buy
2,793
+624
+29% +$63.1K 0.06% 331
2025
Q1 		$219K Buy
+2,169
New +$218K 0.04% 406

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Personal CFO Solutions's BSX Position: Q2 2026 in Review

Personal CFO Solutions sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,939 shares — an estimated $310K sold.

Personal CFO Solutions first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $866K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Personal CFO Solutions reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Personal CFO Solutions sold 4,939 Boston Scientific shares in Q2 2026, an estimated $310K.
  • Personal CFO Solutions first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
  • Personal CFO Solutions's Boston Scientific position peaked at $866K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.